.lipovitan
Is .lipovitan a real TLD? Who’s applying to run it?
.lipovitan is not contested. One application for it is on ICANN’s Reveal Day list, as of 7 October 2026. It is Taisho Pharmaceutical Co., Ltd..
A closed company-brand ending for one product line; useful only to its owner, with no public registrations or resale market.
the applicant's own marketing and product teams, using it for campaign and product addresses under a single brand; nobody else can register on it
The 2012 applications making the most similar bet. Chosen by AI from every string in that round, without being told what happened to any of them.
Both are a single trademarked product of a pharmaceutical company put forward as its own namespace, so the bet is that one consumer drug brand carries enough standalone recognition to host an identity separate from the maker's corporate domain.
A portfolio product mark owned by a diversified consumer-goods parent, betting that the SKU's brand equity — not the company's — is what customers type and trust.
Same structure of a mass-market single-product brand under a parent whose own name stays off the string, though a household non-ingestible sits slightly further from a pharma-origin consumable.
What a .lipovitan domain is
.lipovitan is not a TLD yet. It is a string on our record of the ICANN 2026 new gTLD round, filed under Brand. One application for it is on ICANN’s Reveal Day list.
Is the .lipovitan domain extension real yet?
.lipovitan is not yet a domain extension you can register: nothing resolves under it, and no registrar sells names in it. It is a string applicants have put forward in the ICANN 2026 new gTLD round, the process that decides whether it becomes one.
When can you buy a .lipovitan domain?
You can’t yet. ICANN publishes every applied-for string on Reveal Day, 7 October 2026 at 18:00 UTC. A .lipovitan name can only be registered after that, once the string is delegated and its registry opens.
Is .lipovitan a real TLD?
Not yet. .lipovitan is not in the DNS root, so nothing resolves under it. It’s here because .lipovitan is on ICANN’s Reveal Day list of applied-for strings. Every entry on this page links to its source.
- Taisho Pharmaceutical Co., Ltd. · first recordedICANN
“TPCL2648T-T11392 · Taisho Pharmaceutical Co., Ltd. · primary”ICANN
- Band chosen: 10-29 (vanity/narrow). The record shows a single confirmed application typed 'brand' from Taisho Pharmaceutical Co., Ltd., so this would operate as a closed dot-brand where the registry is the only registrant; the string is, to my knowledge, a consumer product name rather than a generic word, so there is no third-party demand to serve. It is not in the 30-49 band because registrations at volume or on price cannot happen on a closed brand space and there is no aftermarket at all. It is not in the 1-9 band because a dot-brand does have one realistic user: the owner can run product, campaign and regional addresses on it, and by analogy with earlier-round dot-brands (flagged as analogy) some companies have made such a space their public web identity, which is a genuine if narrow end-use. Analogy from the previous round suggests most single-product dot-brands stay lightly used or are used for redirects, which keeps the score near the low end of the band. Main market uncertainty: whether the owner will treat the space as the product's primary online identity across its markets, or keep it as a defensive or redirect-only holding over the next 5 years.